The vaccines are intended to be developed for use against Marburg virus and Sudan ebolavirus, two hemorrhagic fevers in the ...

The US Department of Health and Human Services is weighing whether to fund new Marburg and Sudan Ebola virus vaccines even as Secretary Robert F. Kennedy Jr. overhauls the US immunization landscape, ...

Donald Trump again has threatened a tariff on imported drugs, but has given the drug makers a year or so "to get their act ...

Swenson, D. L. et al. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections. Vaccine 23, 3033–3042 (2005).

The pharmaceutical giant Moderna is developing the first mRNA vaccine to protect against Marburg, a close but even deadlier cousin of Ebola. The haemorrhagic fever, which transmits to humans via ...

As the world marks World Zoonoses Day today, Wild Africa is calling for urgent and consistent action to reduce the risk of ...

CSL will consolidate its R&D teams around six sites located in biotech hubs as the company looks to boost external ...

By law, the withdrawal cannot take full effect until early 2026, due to a required one-year notice period. But the order also instructed an immediate halt to US contributions and a phased pullout of ...

Several recent developments point to Kigali’s growing role in Africa’s biopharmaceutical landscape. Rwanda has positioned itself as a strategic hub through a combination of investment in scientific ...

A drug that targets two parts of the deadly Nipah virus protects against infection in hamsters. And once an animal is ...

Pediatricians like me are worried that Robert F. Kennedy Jr.’s vaccine advisers will make it harder for children to get the ...